News

Executive Summary

• Clee Medical closes its Seed financing round to accelerate development of its real-time intraoperative brain imaging platform, Neuro Access.
• The round is led by High-Tech Gründerfonds (HTGF), with participation from Zürcher Kantonalbank, Kickfund, FONGIT, and Venture Kick who join existing investors the Wyss Geneva for Bio and Neuroengineering.
• The financing will support product development, clinical validation, and regulatory preparation.
  
  

Geneva, Switzerland, 25 February 2026 - Clee...

Clee Medical is proud to celebrate its first anniversary, marking a year of rapid growth, clinical progress, and technological achievement on its mission to enable safer, more precise, and more effective neurosurgery.

Since its founding as a spin-out from the Wyss Center, Clee Medical has evolved from a research concept into a leading force in real-time intraoperative imaging and AI-guided navigation. Over the past year, the team has reached several major...

Clee Medical has been recognized among Switzerland’s most promising startups, ranking #56 in the 2025 Swiss Top 100 Startups. The Swiss Top 100 Startups ranking showcases the country’s most innovative and high-potential young companies. Compiled annually by a jury of leading venture capitalists, investors, and industry experts, the list highlights Switzerland’s thriving startup ecosystem across deep tech, life sciences, and digital innovation.

This recognition marks another important milestone in Clee Medical’s...

Clee Medical is proud to announce a strategic partnership with the Swiss Foundation for Innovation and Training in Surgery (SFITS) to accelerate the clinical validation and adoption of its real-time intraoperative imaging and AI-guided navigation technology.

This collaboration marks a significant milestone in Clee Medical’s mission to empower neurosurgeons with real-time visualization of brain anatomy and vasculature at unprecedented precision. By integrating ultra-high-resolution imaging with AI-based anatomical detection, the company’s Neuro...

Clee Medical is proud to announce that it has been named a winner of the »venture» 2025 startup competition, Switzerland’s leading entrepreneurship award. Selected from a record 396 applicants, this recognition highlights Clee Medical’s pioneering work in developing next-generation neurotechnology for real-time intraoperative brain imaging and AI-guided navigation.

The »venture» competition, founded by ETH Zurich, McKinsey & Company, Knecht Holding, Innosuisse, and other key partners, celebrates Switzerland’s most promising early-stage companies. The 2025 jury...

Clee Medical Advances to the Next Stage of the W.A. de Vigier Award 2025 🎉

We are excited to share that Clee Medical has been selected as one of the 15 startups advancing to the next stage of the prestigious W.A. de Vigier Award 2025!

The W.A. de Vigier Award is Switzerland’s longest-standing prize for young entrepreneurs, recognizing innovative startups that have the potential to make a significant impact in...

Clee Medical Wins Future of Health Grant 2025 🎉

We are thrilled to announce that Clee Medical has been selected as one of the six startups to receive the prestigious Future of Health Grant 2025 amonst 243 applicants!

The Future of Health Grant, initiated by CSS and EPFL Innovation Park, recognizes and supports groundbreaking startups that are shaping the future of healthcare. This recognition is a testament to our commitment...

Exciting Milestone: Our First Scientific Paper Published in Biomedical Optics Express!

We are thrilled to announce the publication of our first scientific technical paper, “Minimally-invasive common-path OCT system for neurosurgery applications” in Biomedical Optics Express. This marks a significant milestone for our team at Clee Medical as we advance the frontiers of neurosurgical imaging technology.

Our research presents a groundbreaking optical coherence tomography (OCT) system tailored specifically for neurosurgery. This minimally...

Real-Time Precision: Overcoming the Limitations of MRI in Neurosurgery

In stereotactic neurosurgery, procedures such as neuromodulation, biopsies, stereoelectroencephalography (sEEG), and lesioning demand sub-millimeter precision to achieve their intended therapeutic effect. However, current imaging methods—most commonly MRI (Magnetic Resonance Imaging)—pose significant limitations that impact surgical accuracy and outcomes. At Clee Medical, we have developed an intraoperative imaging system designed to overcome these challenges, enabling real-time neural targeting with micron-level precision.

The...

Clee Medical, a neuro technology start up focused on transforming the landscape of brain treatments. Officially incorporated in October 2024, Clee Medical is proud to spin out of the Wyss Center in Geneva, Switzerland. With a vision to revolutionize neurointerventional precision and outcomes, Clee Medical is at the forefront of developing cutting-edge, minimally invasive neurotechnologies that empower clinicians with real-time imaging, AI-driven navigation, and machine learning insights for true confidence in neural targeting. Clee Medical’s...